CD274 and neoplasm: Nonetheless, high resolution signals obtained with the nanobody-based PD-L1 radiotracer could allow a trained physician to correctly interpret the images, thereby opening perspectives to evaluate response to therapy based on high peripheral and tumor PD-L1 signals early after vaccination, and to propose an optimal combination regimen.